Finally, our clinical database analysis showing that high MDM2 expression correlates with better survival outcomes in colon cancer patients aligns with some studies suggesting that MDM2 may have p53-independent roles in promoting cell survival (Bhatia et al., 2023). Here, TP53 is linked to colonic neoplasm.